AAAAAA
Results:
1-10
|
Results: 10
Authors:
KOHNO T
MURASUGI N
SAKURAI H
WATABE K
NAKAMUTA H
KOIDA M
SUGIE Y
OGOUCHI T
INOUE T
YANAKA M
NOMURA M
YANAGAWA A
Citation: T. Kohno et al., DETERMINATION OF THE BIOAVAILABILITY OF INTRANASAL ELCATONIN IN HUMANS - DEVELOPMENT OF A SANDWICH TRANSFER ENZYME-IMMUNOASSAY FOR ELCATONIN, Journal of clinical laboratory analysis, 12(6), 1998, pp. 356-362
Authors:
KOHNO T
MURASUGI N
SAKURAI H
WATABE K
NAKAMUTA H
KOIDA M
SUGIE Y
NOMURA M
YANAGAWA A
Citation: T. Kohno et al., DEVELOPMENT OF A HIGHLY SENSITIVE AND SPECIFIC 2-SITE ENZYME-IMMUNOASSAY FOR PARATHYROID-HORMONE-(1-34) - APPLICATION TO PHARMACOKINETIC STUDY ON INTRANASAL PARATHYROID-HORMONE-(1-34) IN HUMAN, Journal of clinical laboratory analysis, 12(5), 1998, pp. 268-275
Authors:
KOHNO T
MURASUGI N
SAKURAI H
WATABE K
NAKAMUTA H
KOIDA M
SUGIE Y
NOMURA M
YANAGAWA A
Citation: T. Kohno et al., A SANDWICH TRANSFER ENZYME-IMMUNOASSAY FOR SALMON-CALCITONIN - DETERMINATION OF THE BIOAVAILABILITY OF INTRANASAL SALMON-CALCITONIN IN HUMAN, Journal of clinical laboratory analysis, 11(6), 1997, pp. 380-387
Authors:
NAKAMUTA H
KOHNO T
ICHIKAWA M
HOSHINO T
WATABE K
KOIDA M
Citation: H. Nakamuta et al., PLASMA-LEVEL MONITORING OF NASAL SALMON-CALCITONIN IN THE RAT BY A HETEROGENEOUS 2-SITE ENZYME-IMMUNOASSAY, Journal of clinical laboratory analysis, 11(3), 1997, pp. 129-131
Authors:
NITTA T
HOSHINO T
KOIDA M
NAKAMUTA H
Citation: T. Nitta et al., HISTOMORPHOMETRICAL EVALUATION OF ANTI-OSTEOPENIC EFFECT OF NASAL SALMON-CALCITONIN IN A TYPE-1 OSTEOPOROTIC MODEL OF RATS, Biological & pharmaceutical bulletin, 19(2), 1996, pp. 214-216
Authors:
NAKAMUTA H
NITTA T
HOSHINO T
KOIDA M
Citation: H. Nakamuta et al., GLUCOCORTICOID-INDUCED OSTEOPENIA IN RATS - HISTOMORPHOMETRICAL AND MICROARCHITECTURAL CHARACTERIZATION AND CALCITONIN EFFECT, Biological & pharmaceutical bulletin, 19(2), 1996, pp. 217-219
Authors:
KOHNO T
NAKAMUTA H
ICHIKAWA M
WATABE K
KOIDA M
Citation: T. Kohno et al., A NONCOMPETITIVE ENZYME-IMMUNOASSAY (HETERO-2-SITE ENZYME-IMMUNOASSAY) FOR SALMON-CALCITONIN - DETERMINATION OF THE BIOAVAILABILITY OF SUBCUTANEOUS SALMON-CALCITONIN AND ITS CORRELATION WITH THE HYPOCALCEMIC ACTIVITY IN RATS, Journal of clinical laboratory analysis, 10(2), 1996, pp. 91-97
Authors:
NAKAGAWA T
UKAI K
OHYAMA T
KOIDA M
OKAMURA H
Citation: T. Nakagawa et al., EFFECTS OF THE SYNTHESIZED GROWTH-HORMONE RELEASING PEPTIDE, KP-102, ON GROWTH-HORMONE RELEASE IN SODIUM GLUTAMATE MONOHYDRATE-TREATED LOW GROWTH RATS, Life sciences, 59(9), 1996, pp. 705-712
Authors:
ICHIKAWA M
NAKAMUTA H
HOSHINO T
OGAWA Y
KOIDA M
Citation: M. Ichikawa et al., ANTI-OSTEOPENIC EFFECT OF NASAL SALMON-CALCITONIN IN TYPE-1 OSTEOPOROTIC RATS - COMPARISON WITH SUBCUTANEOUS DOSING, Biological & pharmaceutical bulletin, 17(7), 1994, pp. 911-913
Authors:
ICHIKAWA M
WANAKA M
OHTSUJI T
AKASHI S
MACHIDERA Y
MANNO K
NAKAMUTA H
KOIDA M
Citation: M. Ichikawa et al., ANTIHYPERTENSIVE EFFECTS OF A NOVEL CALCIUM-ANTAGONIST, SEMOTIADIL FUMARATE (SD-3211), ALONE AND IN COMBINATION WITH ENALAPRIL OR TRICHLORMETHIAZIDE IN SPONTANEOUSLY HYPERTENSIVE RATS, Biological & pharmaceutical bulletin, 17(11), 1994, pp. 1513-1515
Risultati:
1-10
|